🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share comparison photos, injection guides and claims of rapid British shipping. Vendors promote the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals injecting products of unknown origin.

Several experts stated the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Service Response and Content Elimination

According to the social media company, the service has removed problematic material and prohibited related keywords and search suggestions. The organization said it was committed to keeping the service safe and investing in enhancing compliance measures.

Online Marketplace Activities

Research also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or administering at residence.

After minutes of entering one community, a vendor shared WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and promised delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, health issues or past usage.

Product Details and Pricing

Within these communities, posts display black plastic packages with Royal Mail labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A representative for Telegram said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they can’t verify. Although the science behind retatrutide is sound, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject patients to potentially serious medical dangers”.